Follow the VERMILLION, INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 1 February 2016 (Acquisition). Among the most active insiders: SCHULER JACK W. Every trade is openly available.
9
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate VERMILLION, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental score
Ranked 22,048 of 29,064 companies
33.9
score / 100
Value
23
Quality
45
FCF yld-4.0%
Earn yld-5.0%
EV/EBITDA·
ROE-40%
Gross mgn64%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
57,749 sharesCommon Stock, par value $0.001 per shareSEC:0001140361-16-048188:1
Canonical exit: 18 Apr 2016 (T+90)
9 of 9 declarations
Acerca de VERMILLION, INC.
VERMILLION, INC. es una empresa que cotiza en el mercado XNAS, especializada en el desarrollo de soluciones de diagnóstico para enfermedades relacionadas con la salud de la mujer. Se centra en la innovación en el campo de las pruebas de diagnóstico.